Loss of Smad4 drives vascular malformations via c-KIT–dependent high–fluid shear stress mimicry
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci197609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Johannes Gahn und 15 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Pharmacology Mannheim (EPM) and. Hauptthemen laut MEDLINE: Smad4 Protein, Proto-Oncogene Proteins c-kit, Arteriovenous Malformations, Loss of Function Mutation. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, DFG, China Scholarship Council.
Abstract (Originalsprache)
Vascular endothelial cells (ECs) encode a homeostatic fluid shear stress (FSS) set point that is essential for vascular stability. Deviations above or below this threshold trigger adaptive remodeling to restore physiological shear levels. Disruption of this control mechanism leads to enlarged arteriovenous malformations (AVMs) in hereditary hemorrhagic telangiectasia, a vascular disorder caused by heterozygous loss-of-function (LOF) mutation in ALK1 , ENG , or SMAD4 . Mechanistically, Smad4 -deficient ECs are reset to a lower FSS set point value, resulting in AVMs that show characteristics of high-FSS remodeling with elevated KLF4 and high activation of the downstream Akt. Here, we investigated the KLF4/Akt upstream mechanisms by which SMAD4 sets the physiological FSS set point. We identified the receptor tyrosine kinase c-KIT as a component and regulator of the junctional mechanosensory receptor complex, which is highly upregulated in murine and human AVMs. SMAD4 restrains flow signaling by limiting c-KIT–dependent ERK5 activation and KLF4 induction. Thus, SMAD4 LOF leads to sustained c-KIT engagement in the sensory junctional apparatus, driving enhanced and prolonged activation of the ERK5/KLF4/Akt signaling axis. These results show that Smad4 -LOF mutations induce malformations by disabling a key homeostatic mechanism and identify c-KIT as a potentially previously unrecognized therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental Pharmacology Mannheim (EPM) and.
- Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
- German Centre for Cardiovascular Research (DZHK), Mannheim, Germany.
- Ion Chiricuta Oncological Institute, Cluj Napoca, Romania.
- Department of Otorhinolaryngology, Regensburg University Medical Center, Regensburg, Germany.
- Department of Otorhinolaryngology, Head and Neck Surgery, Luzerner Kantonsspital, Lucerne, Switzerland.
Förderung
- NHLBI NIH HHS
- DFG
- China Scholarship Council
- NIH USA
Zitieren
APA
Gahn, J., Wu, F., Zhang, Q., Di, Y., Behera, T., Ren, Y., Hashemi, Z., Banerjee, K., Cordero, J., Gherman, C., Andorfer, K., Seebauer, C. T., Mirzapour-Shafiyi, F., Dobreva, G., Schwartz, M. A., & Ola, R. (2026). Loss of Smad4 drives vascular malformations via c-KIT–dependent high–fluid shear stress mimicry. Journal of Clinical Investigation. https://doi.org/10.1172/jci197609
Vancouver
Gahn J, Wu F, Zhang Q, Di Y, Behera T, Ren Y, et al. Loss of Smad4 drives vascular malformations via c-KIT–dependent high–fluid shear stress mimicry. Journal of Clinical Investigation. 2026. doi:10.1172/jci197609
BibTeX
@article{Gahn2026,
author = {Gahn, Johannes and Wu, Fan and Zhang, Qing and Di, Yuxi and Behera, Tanmaya and Ren, Yonggang and Hashemi, Zohrah and Banerjee, Kuheli and Cordero, Julio and Gherman, Claudia and Andorfer, Kornelia and Seebauer, Caroline T and Mirzapour-Shafiyi, Fatemeh and Dobreva, Gergana and Schwartz, Martin A and Ola, Roxana},
title = {Loss of Smad4 drives vascular malformations via c-KIT–dependent high–fluid shear stress mimicry},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci197609}
}
EUVIMED